SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
…, SE Faustini, M Perez-Toledo, S Jossi, E Aldera… - Thorax, 2020 - thorax.bmj.com
Objective To determine the rates of asymptomatic viral carriage and seroprevalence of
SARS-CoV-2 antibodies in healthcare workers. Design A cross-sectional study of asymptomatic …
SARS-CoV-2 antibodies in healthcare workers. Design A cross-sectional study of asymptomatic …
[HTML][HTML] SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
…, K Adeniji, D Agranoff, K Agwuh, D Ail, EL Aldera… - …, 2023 - thelancet.com
Background Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving
limited insights into mucosal defences that prevent viral replication and onward transmission. …
limited insights into mucosal defences that prevent viral replication and onward transmission. …
SARS-CoV-2 seroconversion in health care workers
…, SE Faustini, M Perez-Toledo, S Jossi, E Aldera… - MedRxiv, 2020 - medrxiv.org
Background The correlates of protection against SARS-CoV-2 and their longevity remain
unclear. Studies in severely ill individuals have identified robust cellular and humoral immune …
unclear. Studies in severely ill individuals have identified robust cellular and humoral immune …
[HTML][HTML] Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity
…, K Wanigasooriya, O Pickles, EL Aldera… - Journal of Clinical …, 2020 - Elsevier
Background In January 2020 reports of unidentified severe respiratory illness were described
in Wuhan, China. A rapid expansion in cases affecting most countries around the globe …
in Wuhan, China. A rapid expansion in cases affecting most countries around the globe …
[PDF][PDF] SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers
…, M Perez-Toledo, S Jossi, E Aldera… - A cross-sectional … - pure-oai.bham.ac.uk
Objective To determine the rates of asymptomatic viral carriage and seroprevalence of
SARS-CoV-2 antibodies in healthcare workers. Design A cross-sectional study of asymptomatic …
SARS-CoV-2 antibodies in healthcare workers. Design A cross-sectional study of asymptomatic …
[PDF][PDF] Virtuosity
R Shao - 2019 - academia.edu
Liberalism and virtue ethics can rescue each other. Almost never have the theories
interacted. But their struggles invite an alliance. The trouble dates back to the seventeenth-century …
interacted. But their struggles invite an alliance. The trouble dates back to the seventeenth-century …
[HTML][HTML] Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective …
Background Early in the pandemic it was suggested that pre-existing use of non-steroidal
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …
anti-inflammatory drugs (NSAIDs) could lead to increased disease severity in patients with …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
[HTML][HTML] Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation …
AB Docherty, RH Mulholland, NI Lone… - The Lancet …, 2021 - thelancet.com
Background Mortality rates in hospitalised patients with COVID-19 in the UK appeared to
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …
decline during the first wave of the pandemic. We aimed to quantify potential drivers of this …
[HTML][HTML] Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective …
Background COVID-19 is a multisystem disease and patients who survive might have in-hospital
complications. These complications are likely to have important short-term and long-…
complications. These complications are likely to have important short-term and long-…